IQ at 6 years after in utero exposure to antiepileptic drugs: A controlled cohort study

Neurology

Volumn 84, Issue 4, 2015, Pages 382-390

  Baker, Gus A ^a   Bromley, Rebecca L ^b,c   Briggs, Maria ^c   Cheyne, Christopher P ^a   Cohen, Morris J ^a,d   García Fiñana, Marta ^a   Gummery, Alison ^a   Kneen, Rachel ^a   Loring, David W ^e   Mawer, George ^c   Meador, Kimford J ^f   Shallcross, Rebekah ^a   Clayton Smith, Jill ^b,c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e EMORY UNIVERSITY   (United States)

^f STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; VALPROIC ACID; TRIAZINE DERIVATIVE;

ARTICLE; CHILD; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; ADULT; CHEMICALLY INDUCED; CHILD DEVELOPMENT; COMPARATIVE STUDY; DRUG EFFECTS; INTELLIGENCE; MALE; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDY;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD DEVELOPMENT; EPILEPSY; FEMALE; HUMANS; INTELLIGENCE; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; TRIAZINES; VALPROIC ACID;

EID: 84927661145     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001182     Document Type: Article

References (30)

1. Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-617.
2. DiLiberti JH, Farndon PA, Dennis NR, Curry CJR. The fetal valproate syndrome. Am J Med Genet 1984;19: 473-481.
3. Ardinger H, Atkin J, Blackston R, et al. Verification of the fetal valproate syndrome phenotype. Am J Med Genet 1988;29:171-185.
4. Moore SJ, Turnpenny PD, Quinn A, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 2000;37:489-497.
5. Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004;75:1575-1583.
6. Adab N, Jacoby A, Smith D, Chadwick D. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2001;70:15-21.
7. Gaily E, Kantola-Sorsa E, Hiilesmaa V, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004;62:28-32.
8. Wide K, Henning E, Tomson T, Winbladh B. Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr 2002;91:409-414.
9. Thomas SV, Sukumaran S, Lukose N, George A, Sarma PS. Intellectual and language functions in children of mothers with epilepsy. Epilepsia 2007;48:2234-2240.
10. Meador K, Baker G, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009;360:1597-1605.
11. Nadebaum C, Anderson V, Vajda F, Reutens D, Barton S, Wood A. The Australian Brain and Cognition and Antiepileptic Drugs Study: IQ in school-aged children exposed to sodium valproate and polytherapy. J Int Neuropsychol Soc 2011;17:1-10.
12. Cummings C, Stewart M, Stevenson M, Morrow J, Nelson J. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child 2011;96:643-647.
13. Veiby G, Daltveit AK, Schjølberg S, et al. Exposure to antiepileptic drugs in utero and child development: a prospective population-based study. Epilepsia 2013;54: 1462-1472.
14. Thomas S, Ajaykumar B, Sindhu K, Nair MGB, Sarma P. Motor and mental development of infants exposed to antiepileptic drugs in utero. Epilepsy Behav 2008;13:229-236.
15. Bromley R, Mawer G, Love J, et al. Early cognitive development in children born to women with epilepsy: a prospective report. Epilepsia 2010;51:2058-2065.
16. Nicolai J, Vles JSH, Aldenkamp AP. Neurodevelopmental delay in children exposed to antiepileptic drugs in utero: a critical review directed at structural study-bias. J Neurol Sci 2008;271:1-14.
17. Meador K, Baker GA, Browning N, et al. Fetal antiepileptic drug and folate exposure: cognition at 6 years of age. Lancet Neurol 2013;12:244-252.
18. Deary I, Strand S, Smith P, Fernandes C. Intelligence and educational achievement. Intelligence 2007;35:13-21.
19. Mawer G, Briggs M, Baker GA, et al. Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure 2010;19:112-119.
20. Bromley RL, Mawer G, Briggs M, et al. Prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013;84:637-643.
21. Elliott C. Differential Ability Scales: Administration and Scoring. San Antonio: The Psychological Corporation; 1990.
22. Nelson H. The National Adult Reading Test. London: Nfer-Nelson Publishing; 1990.
23. Molenberghs G, Kenward M. Missing Data in Clinical Studies. New York: Wiley; 2007.
24. Zhang J, Yu K. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. J Am Med Assoc 1998;280:1690-1691.
25. Bouchard T, McGue M. Familial studies of intelligence: a review. Science 1981;212:1055-1059.
26. Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and verbal vs non-verbal abilities at age 3. Brain;2011;134:396-404.
27. Ackers R, Besag F, Wade A, Murray M, Wong I. Changing trends in antiepileptic drug prescription in girls of child-bearing potential. Arch Dis Child 2009;94: 443-447.
28. Morrow JI, Hunt SJ, Russell AJ, et al. Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. Neurosurg Psychiatry 2009;80: 506-511.
29. Harden CL, Meador KJ, Pennell PB, et al; American Epilepsy. Management issues for women with epilepsy-focus on pregnancy (an evidence-based review): II: teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2009;50: 1237-1246.
30. Bittigau P, Sifringer M, Genz K, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain.Proc Natl Acad Sci USA 2002;99:15089-15094.